Pharmaron Beijing Co Ltd (3759)

Currency in HKD
24.90
-1.54(-5.82%)
Closed·
3759 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.8026.20
52 wk Range
14.4534.86
Key Statistics
Bid/Ask
24.88 / 24.90
Prev. Close
26.44
Open
26.2
Day's Range
24.8-26.2
52 wk Range
14.45-34.86
Volume
8.81M
Average Volume (3m)
6.75M
1-Year Change
20.1737%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3759 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
39.20
Upside
+57.43%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Pharmaron Beijing Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

12 Buy
1 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 39.20
(+57.43% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy38.00+52.61%-New CoverageNov 06, 2026
Citi
Buy62.00+149.00%45.00MaintainAug 24, 2026
Nomura/Instinet
Buy32.20+29.32%27.33MaintainJul 27, 2026
Nomura/Instinet
Buy27.33+9.76%26.63MaintainApr 01, 2026
CLSA
Buy28.80+15.66%-MaintainFeb 27, 2026

Earnings

Latest Release
Oct 27, 2026
EPS / Forecast
0.32 / 0.34
Revenue / Forecast
5.19B / 5.09B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.15
Dividend Yield
0.87%
Industry Median 1.15%
Annualized payout
0.23
Paid annually
5-Years Growth
+8.45%
Growth Streak

3759 Income Statement

Compare 3759 to Peers and Sector

Metrics to compare
3759
Peers
Sector
Relationship
P/E Ratio
36.4x33.7x−0.2x
PEG Ratio
2.660.620.00
Price/Book
3.8x3.5x2.6x
Price / LTM Sales
4.0x5.6x2.6x
Upside (Analyst Target)
57.5%32.2%77.0%
Fair Value Upside
Unlock15.0%13.7%Unlock

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.

Employees
25088
Market
Hong Kong

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
467.28M25.46%11.64B
Other Institutional Investors
652.70M35.56%16.25B
Public Companies & Retail Investors
715.43M38.98%17.81B
Total
1.84B100.00%45.7B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shenzhen Xinzhong Kangcheng Investment Partnership Enterprise (Limited Partnership)10.77%197,754,7004,924,092
Citic M&A Fund Management Co., Ltd.10.77%197,754,7004,924,092

People Also Watch

30.86
1651
-2.59%
52.20
9903
-12.42%
490.00
3308
-8.50%
9.325
1133
-5.04%

FAQ

What Is the Pharmaron Beijing Co Ltd (3759) Stock Price Today?

The Pharmaron Beijing Co Ltd stock price today is 24.90 HKD.

What Stock Exchange Does Pharmaron Beijing Co Ltd Trade On?

Pharmaron Beijing Co Ltd is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Pharmaron Beijing Co Ltd?

The stock symbol for Pharmaron Beijing Co Ltd is "3759."

Does Pharmaron Beijing Co Ltd Pay Dividends? What’s The Current Dividend Yield?

The Pharmaron Beijing Co Ltd dividend yield is 0.9%%.

What Is the Pharmaron Beijing Co Ltd Market Cap?

As of today, Pharmaron Beijing Co Ltd market cap is 75.68B HKD.

What Is Pharmaron Beijing Co Ltd's Earnings Per Share (TTM)?

The Pharmaron Beijing Co Ltd EPS (TTM) is 1.15.

When Is the Next Pharmaron Beijing Co Ltd Earnings Date?

Pharmaron Beijing Co Ltd will release its next earnings report on Mar 29, 2027.

From a Technical Analysis Perspective, Is 3759 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Pharmaron Beijing Co Ltd Stock Split?

Pharmaron Beijing Co Ltd has split 2 times.

How Many Employees Does Pharmaron Beijing Co Ltd Have?

Pharmaron Beijing Co Ltd has 25088 employees.

What is the current trading status of Pharmaron Beijing Co Ltd (3759)?

As of Nov 22, 2026, Pharmaron Beijing Co Ltd (3759) is trading at a price of 24.90 HKD, with a previous close of 26.44 HKD. The stock has fluctuated within a day range of 24.80 HKD to 26.20 HKD, while its 52-week range spans from 14.45 HKD to 34.86 HKD.

What Is Pharmaron Beijing Co Ltd (3759) Price Target According to Analysts?

The average 12-month price target for Pharmaron Beijing Co Ltd is 39.20 HKD, with a high estimate of 61.84880855 HKD and a low estimate of 30.27468013 HKD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +57.43% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.